INTRODUCTION
A major block in the critical path of regenerative medicine is the lack of suitable cells to restore function or repair damage. An ''ideal'' cell for cell therapy will possess the following attributes: (1) non-immunogenic, ideally patient derived; (2) controllable proliferation, allowing directed expansion; and (3) regulatable differentiation, with intrinsic restriction to the appropriate lineage. Primary cultures of somatic cells are not ideal, as they possess limited proliferative capacity and gradually lose their differentiated properties. Endogenous progenitor cells exist in various organs, including the lung (Kim et al., 2005; Rawlins et al., 2009; Rock et al., 2009; Barkauskas et al., 2013; Vaughan et al., 2014; Jain et al., 2015) . However, these endogenous progenitor populations are often difficult to identify and isolate, and usually rapidly change in vitro (McQualter et al., 2010) . In certain pathological conditions, they are limited in number and function (Rock and Königshoff, 2012; Randell, 2006) . Therefore, great efforts have been focused on exogenous cell sources. Despite significant progress in generating mature cell types using embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) (Longmire et al., 2012; Mou et al., 2012; Wong et al., 2012; Huang et al., 2013; Firth et al., 2014) , some protocols remain limited by low yield and purity of the desired mature cell types. There is no standardized approach that is applicable to all cell types. Development of personalized therapies based on autologous pluripotent cells remains very expensive. Moreover, for many cell therapy applications the cells will need externally controllable proliferative capacity to maintain homeostasis or respond to injury.
The early steps of reprogramming have recently been the subject of intense investigations (Clancy et al., 2014; Lujan et al., 2015; Shakiba et al., 2015) . Two papers have documented additional alternative PSC states, specifically the F-class cells described by Tonge et al. (2014) , and separate populations expressing identified as either LIN28 high or NANOG high by Zunder et al. (2015) . In this work, we explore the earlier stages of iPSC reprogramming for potentially useful intermediate cell states. Reprogramming is a multistep process comprising initiation, maturation, and stabilization phases (Samavarchi-Tehrani et al., 2010) during continuous expression of exogenous reprogramming factors until the iPSC state is established (Sridharan et al., 2009 ). There is a rapid induction of cell proliferation during the early phase of reprogramming (Woltjen et al., 2009 ). Reprogrammed cells retain epigenetic ''memory'' in the process for significant numbers of doubling, with the cell of origin influencing the molecular epigenetic profile and functional 
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(legend continued on next page) differentiation potential of the iPSCs (Kim et al., 2010; Polo et al., 2010; Shipony et al., 2014) . Herein, to create therapeutically valuable intermediate cellular products, we took advantage of this early proliferation and speculated that even greater residual epigenetic ''memory'' exists early in the reprogramming process.
For proof of principle we chose the lung, for which there has been recent progress in the identification of progenitor cells and their hierarchical relationships Rock et al., 2009; McQualter et al., 2010; Chapman et al., 2011; Barkauskas et al., 2013; Treutlein et al., 2014; Vaughan et al., 2014; Jain et al., 2015) , although there remains an unmet need to produce highly purified epithelial populations. For specificity we selected mature Club cells, which possess limited proliferative capacity in vitro. Interrupted reprogramming resulted in the generation of large numbers of epithelial progenitor-like cells that demonstrated controlled proliferation and restricted differentiation. This was achieved by optimized, controlled, transient induction of reprogramming factors, turning off their expression prior to reaching independent pluripotency ( Figure 1A ). We term these cells ''induced progenitor-like'' (iPL) cells.
Compared with the difficulty of developing directed differentiation protocols for each cell type required, isolation of highly purified populations of adult cells from most organs is already possible using flow-cytometric sorting and cell-culture techniques. These populations, if bestowed with controllable proliferative capacity and limited differentiation potential, would be extremely useful in a variety of regenerative medicine practices, including cell replacement therapy, biohybrid devices, disease modeling, and drug screening for human diseases.
RESULTS

Isolation and Identification of Terminally Differentiated Club Cells
Club cells are secretory cells prominently found in the small bronchioles, identifiable by the presence of Club cell secretory protein (CCSP) (Hackett and Gitlin, 1992) . The mature cells have very limited proliferative capacity. After injury, they are replaced from a pool of ''variant'' Club cells, which are resistant to toxins such as naphthalene. This population also then serves as progenitors for ciliated and mucous cell populations Reynolds and Malkinson, 2010) . To demonstrate the value of the iPL cell approach, we chose to isolate this terminally differentiated population. Following a modified Club cell isolation protocol (Atkinson et al., 2008) Figure 1B ). The EPCAM high population was exclusively Club cells expressing CCSP ( Figure 1C ) and Claudin10 (Zemke et al., 2008) (Figure S1A ), whereas the EPCAM low population contained both Club cells and type II alveolar epithelial (AEC-II) cells ( Figures  1C and S1B ). Club cell-related genes Ccsp, Cyp2f2, Cldn10, Aox3, and Pon1 were detected within both populations with higher levels in the EPCAM high population ( Figures   1D and 1E ). Naphthalene administration results in selective loss of mature Club cells (Stripp et al., 1995 Figure 2A ) showing epithelial colonies with hollow lumina (Figures 2B and 2C) . Time-course analysis indicated that lumen formation occurred as early as day 4 ( Figure S2A ). This lumen formation occurs at least in part via apoptosis (Grant et al., 2006) , marked by caspase-3 expression ( Figure S2B ), and apical-basal polarization (Martin-Belmonte et al., 2008) , as shown by basolateral distribution of EPCAM ( Figure 2C ) and apical expression of ZO-1 ( Figure S2C ). Dox induction for 3 weeks (3w +Dox ) resulted in suppression of CCSP without activation of the pluripotency marker, NANOG ( Figures 2D and 3E ). An additional 2 weeks of Dox treatment (5w +Dox ) resulted in 22.9% ± 8.3% of colonies becoming NANOG positive ( Figure 2E ). In vivo, 3w +Dox cells injected into NOD/SCID mice failed to form tumors or teratomas over a 6-month observation period. In contrast, mice developed teratomas 2-3 weeks after injection with either R1 ESCs (Nagy et al., 1993) or 5w +Dox cells ( Figures   2G and S2D ). Thus, we selected a 3-week induction period during which we achieved the greatest level of expansion without activation of Nanog expression, and hereafter term the 3w +Dox cells Club-iPL cells. During this 3-week period of expansion, cells were serially passaged in the presence of Dox, retained colony-forming potential ( Figure 2H , right y axis), and showed an exponential increase in total cell number ($30-fold expansion) ( Figure 2H , left y axis). Microarray analysis of genome-wide transcriptional changes showed that Club-iPL cells have minimal expression of ESC-related genes (e.g., Nanog, Utf1, Dapp4) and maintained significant overlapping expression of Club cell-related genes ( Figure 2I ).
Interrupted Reprogramming Allows Club-iPL Cells to Return to Their Original Epithelial Phenotype upon Withdrawal of Factors
We assessed the ability of Club-iPL cells to return to their original epithelial phenotype following withdrawal of Dox. Two weeks after withdrawal of Dox (3w +Dox +2w ÀDox ), cells turned off transgene 4F2A expression and downregulated Cyclin D1 ( Figures 3A and 3B ). Expression of the four individual factors was also significantly downregulated ( Figure S3A ). Some epithelial genes, such as Epcam and E-cadherin, were well maintained both with treatment and upon withdrawal of Dox ( Figure S3B ). CCSP, which was markedly suppressed after 3 weeks of Dox treatment, was expressed at robust levels upon withdrawal of Dox (Figures 3C, 3E, 3F, and 3I few NANOG + colonies were observed ( Figures 3G and 3H ).
Unbiased clustering analysis of the genes with a change R3-fold (5,966/24,779 genes) demonstrated that the induced cell groups clustered with the day-0 group (Figure 3J ). Further analysis showed that the expression of large numbers of genes temporally changed during Dox-driven expansion of Club cells but returned upon withdrawal of the factors. These gene clusters were enriched for epithelial genes by gene ontology analysis ( Figure 3K, top) . Other genes demonstrating progressive changes were enriched for metabolism and cell adhesion functions ( Figure 3K , bottom), suggestive merely of adaptation to the in vitro environment. Figure S3C shows a heatmap of the genes shown in Figure 2I across all four groups. 
Interrupted Reprogramming Allows Preservation of Lineage Commitment
Club-iPL Cells Function as Multipotent Bronchiolar Progenitor-like Cells
We evaluated the differentiation potential of Club-iPL cells using a two-step protocol ( Figure 5A ) whereby Club-iPL cells were cultured without Dox for 2 weeks (first step) followed by air-liquid interface (ALI) conditions for 2-3 weeks (second step). The first step of differentiation resulted in upregulation of CCSP ( Figures 5B and 5D ). Under secondstep ALI conditions, iPL cells spontaneously differentiated to MUC5AC-expressing mucin-producing goblet cells (Figure 5E ) and b-tubulin IV-expressing ciliated cells ( Figure 5F ), coinciding with downregulation of Ccsp ( Figure 5B ) and upregulation of Foxj1 mRNA levels ( Figure 5C ). Thus, Club-iPL cells can function as multipotent bronchiolar progenitor-like cells, giving rise to Club, goblet, and ciliated cells ( Figure 5G ).
Club-iPL Cells Are Able to Generate Functional CFTRExpressing Ciliated Epithelium
Cystic fibrosis transmembrane conductance regulator (CFTR), mainly expressed in ciliated epithelium in the lung, encodes a cyclic AMP (cAMP)-regulated chloride channel that plays a critical role in regulating chloride and water transport. Ciliated epithelium derived from iPL cells expressed functional CFTR protein. We observed that 61.9% ± 6.1% of E-cadherin + cells expressed CFTR, consistent with the formation of functional ciliated epithelium with tight junctions ( Figure 6A ). We confirmed the apical membrane localization of CFTR while E-cadherin staining was visualized at the lateral membranes (Figure 6B) . ALI conditioning resulted in CFTR-expressing cells ( Figure 6C ). Gene expression analysis of ALI-conditioned , values are mean ± SD of three independent biological replicates. For (I), data are representative of a minimum of three independent biological replicates. *p < 0.05; **p < 0.001; ***p < 0.0001. Scale bars, 100 mm (E-H).
cells compared with pre-ALI cells showed a reduction of Ccsp expression ( Figure 5B ) and marked upregulation of Cftr ( Figure 6D ), suggesting the appropriate differentiation of expanded Club cells to CFTR-expressing ciliated cells. An iodide efflux assay measuring cAMP agonist stimulation of the CFTR channel suggests that CFTR seen in Club-iPLderived ciliated epithelium was functional and appropriately regulated ( Figure 6E ).
Club-iPL Cells Are Useful in Cell Replacement Therapy for Cystic Fibrosis In Vivo
The engraftment of Club-iPL cells into CFTR-deficient epithelium was assessed in vivo. For tracking purposes, ROSA26-rtTA/Col1a1: tetO-4F2A double transgenic mice were bred to actin GFP mice and GFP + Club-iPL cells were delivered to CFTR-knockout mice transtracheally following our previously reported conditioning regimen (Duchesneau et al., 2010 (Duchesneau et al., , 2017 to augment retention of delivered cells. The engraftment and differentiation capacity of Club-iPL cells in recipient lungs were assessed via staining for ZO-1 or E-cadherin, anti-GFP, and epithelialtype specific markers at 7 and 21 days after cell delivery. CFTR expression in airways of wild-type mice was used as a positive control ( Figure 6F ) while non-treated and naphthalene-treated CFTR-knockout mice served as negative controls ( Figures 6G-6I ). Injected GFP cells expressed ZO-1 and E-cadherin, suggestive of their incorporation in recipient epithelium. CFTR-expressing GFP cells were found at days 7 and 21 ( Figures 6J and 6K ) after iPL cell treatment. Western blotting ( Figure 6L ) confirmed expression of CFTR protein. A faint band of immature hypoglycosylated CFTR was seen in the untreated CFTR-knockout controls, as expected (in this transgenic animal where the lung is known to have low-level expression of human CFTR) (Zhou et al., 1994) . They also increased expression of Ccsp and partially restored expression of Cftr in CFTR-deficient lungs ( Figures 6M and 6N To quantify retention, we measured genomic DNA for GFP using a standard curve. Donor iPL cells were retained in recipient lungs ( Figure S5F ) with no significant difference between 7 days (27.8% ± 12.2% of the initial injected cell number) and 21 days (25.8% ± 12.1%) after cell delivery. We also examined the long-term tumorigenicity of iPL cell lines in vivo (n = 3). Whole body micro-computed tomography scans taken at 9 months after iPL cell delivery showed no tumors ( Figure S5G ).
DISCUSSION
A carefully defined period of interrupted reprogramming enabled quiescent mature Club cells to proliferate and start the reprogramming process, but not pass the point of noreturn , thereby generating large numbers of iPL cells. Upon withdrawal of the inductive factors, iPL cells give rise to CCSP + Club cells, mucin + goblet cells, and functional CFTR-expressing ciliated epithelium in vitro. They show in vivo utility by repopulating CFTR-knockout epithelium after a recipient conditioning regimen. Our results suggest that interrupted reprogramming is not only able to achieve controlled expansion of the selected cell type, but results in the ''dedifferentiation'' of the cells to a progenitor-like state while preserving the differentiation potential of the parental population to generate a limited range of functional progeny. Recent advances in the understanding of the mechanisms involved in iPSC reprogramming have demonstrated that ''epigenetic memory'' found both in human and mouse iPSCs renders them permissive to preferential differentiation to the original lineage (Kim et al., 2010; Bar-Nur et al., 2011; Shipony et al., 2014; De Los Angeles et al., 2015) . In our study, we harnessed this ''residual epigenetic memory'' of the starting cells and generated large numbers of relatively pure progenitor-like populations with intrinsic restriction to the appropriate lineage. (legend continued on next page)
Despite recent progress in delineating a number of lung progenitor populations and some of their associated markers (Chapman et al., 2011; Jain et al., 2015; Kim et al., 2005; McQualter et al., 2010; Rawlins et al., 2009; Rock et al., 2009; Treutlein et al., 2014; Vaughan et al., 2014) , we are still limited in our grasp of the number and characteristics of the lung stem cell hierarchy. After careful comparison using available specific marker expression and microarray data for known lung progenitor populations (Rock et al., 2009; Vaughan et al., 2014) , P63-expressing Club-iPL cells do not resemble any currently identified progenitors ( Figures  S6A-S6H ). It remains a possibility that they represent a yet unidentified progenitor cell population. Alternatively, transient expression of OSKM in mature lung epithelial cells could result in the generation of a progenitor population not existing in the developing or mature lung-that is, bearing no clear relation to cells in the natural state but nonetheless capable of controlled expansion and differentiation to a limited and appropriate range of progeny. Recent reports highlight the existence of multiple unique cell states en route to pluripotency Tonge et al., 2014; Zunder et al., 2015; Treutlein et al., 2016) . Whether or not iPL cells recapitulate a specific developmental stage, enhanced proliferation, and restricted differentiation makes them useful, especially given that this technology can theoretically be applied to almost any cell type that can be isolated and purified.
Superior self-renewal and differentiation capacity of ESCs and iPSCs make both very useful for regenerative medicine, but protocols to generate large numbers of pure, fully differentiated cells are still imperfect. Problems include low differentiation efficiency, heterogeneous final products (Plath and Lowry, 2011; Schwartz et al., 2014) , and contamination by potentially tumorigenic undifferentiated cells (Ben-David and Benvenisty, 2011; Tapia and Schöler, 2016) . A variety of approaches may overcome these problems, but producing each unique cell that may be desirable will require the development of hundreds of unique protocols. Direct reprogramming through ectopic expression of combinations of specific transcription factors (Caiazzo et al., 2011; Sancho-Martinez et al., 2012) and/or micro-RNA (Ambasudhan et al., 2011; Leonardo et al., 2012) , resulting in direct conversion from one cell type to another, has also been extensively studied. Direct conversion does not require a pluripotent intermediate state and thus may raise fewer safety concerns. Our interrupted reprogramming strategy similarly avoids pluripotency but may be easier to apply to a broad range of cell types, only requiring that they can be isolated in relative purity.
Recent studies showed in vitro differentiation of iPSCs and ESCs to lung epithelium, but were not able to generate large numbers of either Club cells or ciliated cells. Importantly, none of these groups evaluated the in vivo contribution of resultant CFTR-expressing cells in an animal model. On the contrary, our iPL cells hold great promise for treating respiratory diseases. Our proof-of-concept in vivo studies showed successful retention and incorporation in CFTR-deficient epithelium, with injected iPL cells being able to give rise to both Club cells and ciliated cells.
The significance of this concept results in a number of key issues that need to be addressed. Firstly, our current report suggested that iPL cells are not yet pluripotent. However, our proof-of-principle study was performed using a Dox-inducible polycistronic OSKM system that is known to have a low efficiency for generating bona fide iPSCs, and the absolute safety of this approach requires further evaluation in different OSKM expression systems. Secondly, although we have selected a highly purified population of cells as the starting material, interrupted reprogramming still produces clones that are variable in size, suggesting some degree of heterogeneity in the system. While proliferation during iPL induction seems relatively uniform ( Figure 1H , middle panel) and the observed return to phenotype upon Dox withdrawal ( Figure 2I ) is also homogeneous, potential pluripotency (as suggested by NANOG expression) is more heterogeneous, varying between colonies and among cells within an individual colony after a prolonged induction period (>5 weeks). This will need further exploration but is not surprising, as evidence suggests higher levels of heterogeneity in the early phases of iPSC induction Treutlein et al., 2016; Zunder et al., 2015) . There is also some heterogeneity in the differentiation capacity of the Club cells after return from the iPL state, although this can be attributed to the normal biology of Club cells Reynolds et al., 2000) . We also explored the potential of cyclical interrupted reprogramming for even greater expansion of iPL cells in vitro ( Figures  S6I-S6K ) and in repopulating injured airway epithelium in vivo (Figures S6L-S6P ). While significant increases in (D-F) Confocal microscopy images showing (D) immunostaining of iPL cells after the first step in the differentiation protocol, with nuclear stain DAPI (blue), Pan-CK (red), and CCSP (green); immunostaining of cells after the second step of differentiation protocol with (E) nuclear stain DAPI (blue), E-cadherin (red), and MUC5AC (green) (arrowheads, MUC5AC high cells); and with (F) nuclear stain DAPI (blue) and b-tubulin IV (green). (G) Schematic graph depicting the differentiation capacity of 3w +Dox (Club-iPL) cells. For (B) and (C), values are mean ± SD of three independent biological replicates. *p < 0.05; **p < 0.001; ***p < 0.0001. Scale bars, 10 mm (D-F).
cell numbers were seen, the number of cycles resulting in maximal expansion of cells without loss of iPL function remains to be determined. Further refinement is needed to widen the relatively narrow time window during which iPL cell induction and expansion is maximized but before potential factor-independent pluripotency is possible. This may require optimization of exogenous growth factors and/or changes to culture conditions. In addition, the precise requirement for each individual transcription factor remains unknown. Future studies need to be performed to clarify the mechanism underlying the iPL phenomenon and examine whether all factors are necessary. Singovski and colleagues evaluated the effect of transient activation of OSKM, OSK, and M alone (Singovski et al., 2016) . While c-Myc was important for driving proliferation, only the full four factors resulted in acquisition of a robust ''cancer stem cell'' phenotype, including increase in colony-forming efficiency. This suggests that the combination of all four factors has downstream effects beyond simply Myc-driven proliferation. Whether this observation is analogous to our non-malignant ''progenitor-like'' population remains to be studied. Finally, regarding therapeutic use, the current data were obtained from Col1a1-4F2A mice and it remains to be shown that this technique can be efficiently applied in human cells. In preliminary studies, we isolated normal human lung epithelial cells containing Club cells from excess tissue remaining from lung transplant donors. Cells were transfected with a polycistronic lentiviral vectors driving Dox-regulatable OSKM. Although the induction conditions require further optimization, Dox-induction resulted in increased cell numbers compared with nontreated native epithelial cells ( Figure S6Q ). Importantly, consistent with our observation in the mouse system, Dox-treated cells lost their somatic CCSP gene expression but regained it following Dox-withdrawal, suggestive of the ability to return to their original phenotype ( Figure S6R ). The iPL cell induction process will need to be optimized to obtain maximum expansion and scale-up of cells, but should theoretically benefit from the advances driving iPSC research toward non-integrative, non-viral methods of reprogramming. Theoretically, our iPL concept is broadly applicable and could be extended to other somatic cell types, giving rise to numerous progenitor cell populations. Although future investigations will be needed, these proof-of-concept in vivo studies showed that iPL cells hold great promise for treating respiratory diseases by true engraftment as ''induced'' progenitors.
EXPERIMENTAL PROCEDURES
Naphthalene Administration and Cell Delivery
Naphthalene (>99% pure; Sigma-Aldrich, St Louis, MO) was dissolved in Mazola corn oil and injected as described previously (Stripp et al., 1995) . Busulfan (Otsuka America Pharmaceutical, Rockville, MD) was given by intraperitoneal injection 1 day after naphthalene treatment at a dose of 20-50 mg/kg, and donor cells were transplanted the following day (10 6 cells in 50 mL of PBS) transtracheally using sterile gel-loading tips. The mice receiving donor cells were rotated to ensure equal dispersion of cell suspension to both lungs.
Cell Culture
Matrigel-Based iPL Cell Induction (BD Biosciences) prediluted 1:1 (v/v) with epithelial-specific medium were added to MEF-coated 24-well transwell filter inserts in a 24-well tissue culture plate containing 500 mL of epithelial medium for 3-5 days, then replaced with ESC medium containing 1.5 mg/mL doxycycline (Sigma). Medium was replenished three times per week. For bulk passaging, whole cultures were dissociated in collagenase (1 mg/mL; Sigma)/dispase (3 mg/mL; BD Biosciences) in PBS to generate a single-cell suspension. For clonal passaging, single colonies were picked and dissociated.
In Vitro Differentiation Assays
To examine the in vitro potential of these cells to differentiate along certain lineages, we performed a variety of differentiation assays. iPL cells induced for 3 weeks were compared with a positive control group consisting of cells exposed to reprogramming factors for 8 weeks.
Air-Liquid Interface Differentiation Assay
Prior to the ALI assay, induced cells were cultured and recovered in ESC medium for 2 weeks. For ALI culture, the ESC medium from the upper chamber was removed to expose cells to the air while medium in the lower chamber was replaced with ALI-specific medium (Lonza). Medium was replenished twice per week and cells were maintained under ALI conditions for 2-3 weeks.
In Vitro Pluripotency Assay
An in vitro pluripotency assay to assess the potential of these cells to develop into a variety of cell lineages was performed (Levenberg et al., 2003) . In brief, induced cells were dissociated and digested to single-cell suspension and then resuspended in 50% (Matrigel) and 20% fetal bovine serum containing medium supplemented with: activin-A (20 ng/mL), transforming growth factor b1 (2 ng/ mL), 10 g/mL insulin, 5 g/mL transferrin, and 300 ng/mL retinoic acid for 2-3 weeks. Lineage differentiation was assessed by immunostaining of pan-cytokeratin, a-actinin, and b-tubulin III.
Neuron Differentiation Assay
To determine the lineage commitment of induced cells, we performed a defined neuron differentiation assay (Millipore) with slight modifications. In brief, 3-week-and >8-week-induced cells from Matrigel cultures were digested to single-cell suspension and differentiated under neuron-specific conditions for 2-3 weeks following the manufacturer's protocol. Generation of neurons was accessed by immunostaining of b-tubulin III.
Microarray and Data Analysis
Total RNA was extracted using an RNeasy kit (Qiagen, Canada). Equal amounts of RNA from three separate samples in each group were used for microarray. Microarray expression profiling using Mouse Gene 2.0 ST chips was performed by The Center for Applied Genomics (The Hospital for Sick Children, Toronto, Canada). Gene ontology term analysis was performed by the DAVID Bioinformatics tool. Self-organizing map analysis of gene expression was performed with the use of the analysis tool MultiExperiment Viewer.
ACCESSION NUMBERS
The microarray data were deposited in the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) under accession number GEO: GSE105775. 
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